2005 Pancreatic Cancer Facts
In America, one in three women, and one in two men will be diagnosed with cancer in their lifetime.
Approximately 32,180 people will be diagnosed with Pancreatic Cancer this year in the United States and 31,800 people will die.
Pancreatic Cancer has the #1 fatality rate of all cancers.
Pancreatic Cancer is the 4th leading cause of cancer death in the United States.
The 99% mortality rate for pancreatic cancer is the highest of any cancer.
Pancreatic Cancer does not discriminate by age, gender or race and only 4% of patients will survive beyond 5 years.
The average life expectancy after diagnosis with metastatic disease is just 3-6 months.
No effective early detection methods have been developed, there are minimal treatment options available and very little research is under way due to limited research funding.
An estimated 36.5 million dollars was spent on pancreatic cancer research in 2003 of the National Cancer Institute’s (NCI) cancer research budget. This is just a mere 0.8 of 1% of the NCI’s 4.592 billion dollar cancer research budget for 2003.
Despite the especially lethal nature of pancreatic cancer, the research spending per pancreatic cancer patient is only $1145, the lowest of any leading cancer.
It is time to take action against a disease that has been ignored for too long.
We have the power to do something about this disease.
You have the power to help us.
Working Together for a Cure!
www.pancan.org
877-272-6226
In America, one in three women, and one in two men will be diagnosed with cancer in their lifetime.
Approximately 32,180 people will be diagnosed with Pancreatic Cancer this year in the United States and 31,800 people will die.
Pancreatic Cancer has the #1 fatality rate of all cancers.
Pancreatic Cancer is the 4th leading cause of cancer death in the United States.
The 99% mortality rate for pancreatic cancer is the highest of any cancer.
Pancreatic Cancer does not discriminate by age, gender or race and only 4% of patients will survive beyond 5 years.
The average life expectancy after diagnosis with metastatic disease is just 3-6 months.
No effective early detection methods have been developed, there are minimal treatment options available and very little research is under way due to limited research funding.
An estimated 36.5 million dollars was spent on pancreatic cancer research in 2003 of the National Cancer Institute’s (NCI) cancer research budget. This is just a mere 0.8 of 1% of the NCI’s 4.592 billion dollar cancer research budget for 2003.
Despite the especially lethal nature of pancreatic cancer, the research spending per pancreatic cancer patient is only $1145, the lowest of any leading cancer.
It is time to take action against a disease that has been ignored for too long.
We have the power to do something about this disease.
You have the power to help us.
Working Together for a Cure!
www.pancan.org
877-272-6226